Effect of dietary Lycium barbarum polysaccharide on growth performance and immune function of broilers

被引:30
作者
Liu, Y. L. [1 ]
Yin, R. Q. [1 ]
Liang, S. S. [1 ]
Duan, Y. L. [1 ]
Yao, J. H. [1 ]
Duan, Y. L. [1 ]
Yang, X. J. [1 ]
机构
[1] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China
关键词
Lycium barbarum polysaccharide; immunity; performance; lymphocyte; broiler; NF-KAPPA-B; PROTEIN COMPLEX; ASTRAGALUS-POLYSACCHARIDE; T-CELLS; GENE-EXPRESSION; LIPOPOLYSACCHARIDE; ANTITUMOR; CHICKENS; SYSTEM; FRUIT;
D O I
10.3382/japr/pfw063
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Lycium barbarum polysaccharide (LBP) is a traditional Chinese herbal medicine possessing many properties such as anti-oxidant and immunomodulation. This study was conducted to evaluate the clinical efficacy of LBP in broilers. A total of 240 newly hatched broilers were randomly allotted into 4 treatments with 6 replicates. Diets in 3 treatment groups were supplemented with 2, 4, and 8 g/kg LBP, respectively, based on the control diet. Lymphocytes isolated from broiler blood were used to detect immunoregulation function of LBP in vitro. Results in vivo showed that average daily feed intake (ADFI) and feed conversion ratio (FCR) in the 4 g/kg LBP group were decreased significantly (P < 0.05). Dietary 4 g/kg LBP significantly increased immune organ indexes of broilers at 21 d (P < 0.05). Moreover, levels of serum total protein, globulin, albumin, and lysozyme of broilers were higher in the 8 g/kg LBP group (P < 0.05). CD4+/CD8+ ratio in blood T cells was higher in the 4 g/kg LBP group (P < 0.05). Results in vitro suggested that 100 and 1,600 mu g/mL LBP supplementation significantly promoted blood B and T lymphocyte proliferation of broilers, respectively (P< 0.05). TNF-alpha mRNAabundance was observably decreased in the lower LBP concentration groups (P < 0.05). In conclusion, LBP may possess the clinical efficacy for growth promotion and immunomodulation and could be used as an alternative for nutritive additive in broilers.
引用
收藏
页码:200 / 208
页数:9
相关论文
共 40 条
[1]   A review of botanical characteristics, phytochemistry, clinical relevance in efficacy and safety of Lycium barbarum fruit (Goji) [J].
Amagase, Harunobu ;
Farnsworth, Norman R. .
FOOD RESEARCH INTERNATIONAL, 2011, 44 (07) :1702-1717
[2]   Safflower polysaccharides activate the transcription factor NF-κB via Toll-like receptor 4 and induce cytokine production by macrophages [J].
Ando, I ;
Tsukumo, Y ;
Wakabayashi, T ;
Akashi, S ;
Miyake, K ;
Kataoka, T ;
Nagai, K .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2002, 2 (08) :1155-1162
[3]   Scale invariance of immune system response rates and times: perspectives on immune system architecture and implications for artificial immune systems [J].
Banerjee, Soumya ;
Moses, Melanie .
SWARM INTELLIGENCE, 2010, 4 (04) :301-318
[4]  
Brekelmans P, 1990, Semin Immunol, V2, P13
[5]   Activation of T lymphocytes by polysaccharide-protein complex from Lycium barbarum L. [J].
Chen, Zhisong ;
Tan, Benny Kwong Huat ;
Chan, Soh Ha .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2008, 8 (12) :1663-1671
[6]  
Das A. K., 2014, International Journal of Bio-resource and Stress Management, V5, P246, DOI 10.5958/0976-4038.2014.00563.6
[7]   Antibiotic residues in poultry tissues and eggs: Human health concerns? [J].
Donoghue, DJ .
POULTRY SCIENCE, 2003, 82 (04) :618-621
[8]   Decreased regulatory T-cells and CD4+/CD8+ratio correlate with disease onset and progression in patients with generalized vitiligo [J].
Dwivedi, Mitesh ;
Laddha, Naresh C. ;
Arora, Prateek ;
Marfatia, Yogesh S. ;
Begum, Rasheedunnisa .
PIGMENT CELL & MELANOMA RESEARCH, 2013, 26 (04) :586-591
[9]   Immunomodulation and antitumor activity by a polysaccharide-protein complex from Lycium barbarum [J].
Gan, L ;
Zhang, SH ;
Yang, XL ;
Xu, HB .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2004, 4 (04) :563-569
[10]   A polysaccharide-protein complex from Lycium barbarum upregulates cytokine expression in human peripheral blood mononuclear cells [J].
Gan, L ;
Zhang, SH ;
Liu, Q ;
Xu, HB .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 471 (03) :217-222